Analysis of psychiatric contraindications to the use of ketamine as an adjunct in psychotherapy
Psychosomatic Medicine and General Practice · 30.09.2026 · 11 (3)
DOI: 10.26766/pmgp.v11i3.741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychosomatic Medicine and General Practice, online erschienen am 30.09.2026. Verfasst von Viacheslav Zaika und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background and aims. Depression is highly prevalent, and 30%–60% of patients do not respond adequately to standard therapy. Ketamine-assisted psychotherapy (KAP) is a promising approach, but psychiatric contraindications remain unstandardized. This study aimed to systematize mental health-related contraindications to ketamine-assisted therapy. Material and methods. We reviewed 74 publications, selected 15 key guidelines and reviews to compile a unified list of psychiatric contraindications, and then analyzed 126 targeted studies to assess the risks of each condition. Each contraindication was classified as retained, removed, or supported by insufficient evidence.
Results
The conditions were divided into three groups. Schizophrenia, schizoaffective disorder, depression with psychotic symptoms, psychotic symptoms, delirium, mania, bipolar I disorder, cognitive impairments, and eating disorders with somatic decompensation should remain contraindications. ASD, OCD, and untreated sleep apnea may warrant removal, while evidence for Cluster B personality disorders remains insufficient. This structured system may improve patient selection and therapy safety.
Conclusions
This study proposes a three-tier classification of psychiatric contraindications for KAP based on clinical risk. While high-risk disorders should remain restricted, some conditions may be reconsidered for exclusion. Further large-scale studies are needed to refine risk stratification and standardize safety protocols. Keywords: ketamine, ketamine-assisted psychotherapy, treatment-resistant depression, mental disorders, contraindications, treatment safety.
Zitieren
APA
Zaika, V., & Tytarenko, Y. (2026). Analysis of psychiatric contraindications to the use of ketamine as an adjunct in psychotherapy. Psychosomatic Medicine and General Practice, 11(3). https://doi.org/10.26766/pmgp.v11i3.741
Vancouver
Zaika V, Tytarenko Y. Analysis of psychiatric contraindications to the use of ketamine as an adjunct in psychotherapy. Psychosomatic Medicine and General Practice. 2026;11(3). doi:10.26766/pmgp.v11i3.741
BibTeX
@article{Zaika2026,
author = {Zaika, Viacheslav and Tytarenko, Yan},
title = {Analysis of psychiatric contraindications to the use of ketamine as an adjunct in psychotherapy},
journal = {Psychosomatic Medicine and General Practice},
year = {2026},
volume = {11},
number = {3},
doi = {10.26766/pmgp.v11i3.741}
}
EUVIMED